Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Hao Zhang, Lin Liu, Jinbo Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 112
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 36
Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth
Tal Caller, Itai Rotem, Olga Shaihov–Teper, et al.
Circulation (2024) Vol. 149, Iss. 22, pp. 1729-1748
Closed Access | Times Cited: 17
New insights into the role of macrophages in cancer immunotherapy
Zhou Li, Tiantian Zhao, Ruzhe Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion
Ke-Xun Yu, Weijie Yuan, Huizhen Wang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 6
Open Access | Times Cited: 16
Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers
Manli Zhou, Xiaoyun He, Cheng Mei, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
Shumin Xu, Chenyang Wang, Lingge Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations
Xiang Chen, Lingjuan Chen, Xiaofei Peng, et al.
Translational Oncology (2023) Vol. 40, pp. 101851-101851
Open Access | Times Cited: 24
Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy
Q. Chen, XUEJUN GUO, Wenxue Ma
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 1, pp. 49-60
Open Access | Times Cited: 23
Tumor cell senescence-induced macrophage CD73 expression is a critical metabolic immune checkpoint in the aging tumor microenvironment
Yue Deng, Qingyan Chen, Xiao Yang, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1224-1240
Open Access | Times Cited: 14
Immunomodulatory Precision: A Narrative Review Exploring the Critical Role of Immune Checkpoint Inhibitors in Cancer Treatment
Junyu Qiu, Zilin Cheng, Zheng Jiang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5490-5490
Open Access | Times Cited: 13
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Shan Liu, Xingda Zhang, Wenzheng Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Cell Membrane‐Targeting Type I/II Photodynamic Therapy Combination with FSP1 Inhibition for Ferroptosis‐Enhanced Photodynamic Immunotherapy
Jian Chen, Zeyu Duan, Lidong Deng, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 11
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications
Miguel Á. Ortega, Diego Liviu Boaru, Diego De León-Oliva, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 8, pp. 987-1000
Closed Access | Times Cited: 11
Hybrid Cellular Nanovesicles Block PD‐L1 Signal and Repolarize M2 Macrophages for Cancer Immunotherapy
Chenchen Zhao, Yuanwei Pan, Lujie Liu, et al.
Small (2024) Vol. 20, Iss. 31
Closed Access | Times Cited: 8
Radiofrequency radiation reshapes tumor immune microenvironment into antitumor phenotype in pulmonary metastatic melanoma by inducing active transformation of tumor-infiltrating CD8+ T and NK cells
Jia-zheng Jiao, Yang Zhang, Wenjuan Zhang, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 7, pp. 1492-1505
Open Access | Times Cited: 8
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond
Jialin Lu, Yuqing Ma, Q. Quentin Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Case report: A successful case of targeted immunotherapy for locally advanced pancreatic cancer under non-surgical conditions
Yunli Bi, Haotian Yv, Xiaopeng Ma, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Immune microenvironment features underlying the superior efficacy of neoadjuvant immunochemotherapy over chemotherapy in local advanced gastric cancer
Ning Zhang, Chunyu Li, Zehua Zhao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Preclinical application of a CD155 targeting chimeric antigen receptor T cell therapy for digestive system cancers
Kai Zhang, Yang Mi, Bohao Zhang, et al.
Oncogene (2025)
Closed Access | Times Cited: 1
Intraperitoneal programming of tailored CAR macrophages via mRNA-LNP to boost cancer immunotherapy
Sitao Xie, Kedan Gu, Ting Liang, et al.
Research Square (Research Square) (2025)
Open Access | Times Cited: 1
Immunotherapy: an emerging modality to checkmate brain metastasis
Aatiya Ahmad, Parvez Κhan, Asad Rehman, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
Kenny Misael Calvillo‐Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodrı́guez-Padilla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top